High-Risk Lung Cancer Patients May Not Need Annual Screenings

Contact: Sarah Avery Phone: 919-660-1306 Email: sarah.avery@duke.edu https://www.dukehealth.org FOR IMMEDIATE RELEASE on Monday, March 21, 2016 DURHAM, N.C. – Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer Institute researcher. The researchers found that even former heavy smokers appear to have a reduced incidence of lung cancer if their initial LDCT screening is negative, suggesting that less frequent screening might be warranted.  “This has significant public policy implications,” said Edward F. Patz, Jr., M.D., the James and Alice Chen Professor of Radiology at Duke and lead author of a study published online March 21 in The Lancet Oncology journal. “Not screening patients annually could save millions in health care costs and spare patients the radiation exposure and the downstream effects of false positive screenings." Patz and colleagues analyzed data from the National Lung Screening Trial, a large prospective study that randomly assigned former smokers to either receive three annual low-dose CT scans or three chest radiographs for the early detection of lung cancer. Patients were ages 55-74 who had smoked for the equivalent of 30 years (one pack a day for 30 years, two packs a day for 15 years, etc.). The researchers identified study participants in the CT-scan group whose initial scre...
Source: DukeHealth.org: Duke Health Features - Category: Pediatrics Tags: Duke Medicine Source Type: news

Related Links:

Abstract Comorbidities significantly contribute to morbidity, mortality, and health care costs in individuals with chronic obstructive pulmonary disease (COPD). Comorbidity prevalence does not always correlate with lung disease severity and the elevated risk of certain comorbidities is often independent of shared risk factors such as tobacco burden. While COPD management guidelines recognize the importance of identifying and treating comorbidities as part of the comprehensive management of COPD patients, little guidance is provided regarding best screening practices. Whereas universal comorbidity screening in COPD...
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
This study explored patient experience of MR treatment planning scans in addition to a CT scan.
Source: Radiography - Category: Radiology Authors: Source Type: research
Abstract BACKGROUND: Up to 20% of clinical stage I lung cancer patients harbor lymph node metastases that go undetected (missed) during the clinical staging evaluation. We investigated to what degree the addition of invasive nodal staging procedures to imaging, as currently practiced, prevents radiographically-occult nodal metastases from being missed during the clinical staging evaluation. METHODS: Treatment-naïve patients, imaged by PET and CT scanning, that underwent lobectomy for clinical stage I lung cancer from 2012-17 in the Society of Thoracic Surgeons General Thoracic Surgery Database were studi...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research
The evaluation of mediastinal lymph nodes is perhaps the most critical step in the staging of patients with suspected or confirmed non –small cell lung cancer. Current national practice guidelines published by the National Comprehensive Cancer Network1 and the American College of Chest Physicians2 recommend a noninvasive first step with computed tomography and positron emission tomography for all patients, followed by invasive me diastinal staging in patients with radiographic evidence of hilar or mediastinal lymph node involvement, or those with a radiographically normal mediastinum and central tumors3  cm in size.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Commentary Source Type: research
Abstract PURPOSE: To provide evidence-based recommendations to practicing clinicians on radiographic imaging and biomarker surveillance strategies after definitive curative-intent therapy in patients with stage I-III non-small-cell lung cancer (NSCLC) and SCLC. METHODS: ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, radiology, primary care, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 2000...
Source: Ann Oncol - Category: Cancer & Oncology Authors: Tags: J Clin Oncol Source Type: research
The follow-up for radically treated non-small cell lung cancer (NSCLC) patients remains controversial. The aim of this study was to review the outcomes since the change in the local protocol in 2014 were CT scan follow-up introduced, in term of further radical treatment for recurrence as well as 3 years survival.243 patients with NSCLC who treated radically with surgical resection were retrospectively reviewed. Patients treated in 2012-2013 were followed-up by chest radiographs or no specific protocol (Group A), while patients treated in 2015 had CT-Scans follow-up at 6, 12 and 18 months (Group B).Out of 169 patients in gr...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Lung cancer Source Type: research
Introduction: In patients with suspected lung cancer a CT scan should be the initial diagnostic test after chest radiography.Objective: To assess the impact of direct access to CT prior to the first appointment in a rapid access lung cancer clinic on diagnostic and treatment delays.Methods: We analysed patients with suspected lung cancer referred from May 2015 to December 2018. General practitioners and specialists from our health department may request a CT at the time of referral and we use a fast track system to offer patients a CT scan scheduled within 1 week. Information was collected on patient characteristics, date ...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Lung cancer Source Type: research
CONCLUSIONS: This study reveals the associations between CT imaging radiomics features and NSCLC co-expressed gene sets. The findings suggest that CT radiomics features can reflect important biological information of NSCLC patients, which may have a significant clinical impact as CT is routinely used in clinical practice, assisting in improving medical decision-support at low cost. PMID: 31450540 [PubMed - as supplied by publisher]
Source: Journal of X-Ray Science and Technology - Category: Radiology Tags: J Xray Sci Technol Source Type: research
Haibo Hu Lung cancer is one of the major causes of cancer-related deaths due to its aggressive nature and delayed detections at advanced stages. Early detection of lung cancer is very important for the survival of an individual, and is a significant challenging problem. Generally, chest radiographs (X-ray) and computed tomography (CT) scans are used initially for the diagnosis of the malignant nodules; however, the possible existence of benign nodules leads to erroneous decisions. At early stages, the benign and the malignant nodules show very close resemblance to each other. In this paper, a novel deep learning-bas...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
Conclusions: Our study indicates that solid nodules have the highest risk of malignancy. Furthermore, the cytological evaluation of subsolid and partially calcified nodules is crucial for the accurate diagnosis and appropriate clinical management of lung nodule patients.
Source: CytoJournal - Category: Pathology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Health | Health Management | Lung Cancer | Pediatrics | PET Scan | Radiography | Radiology | Smokers | Study